Additionally, the State of California’s Division of Workers’ Compensation will update its MTUS medical guidelines to align with ReedGroup’s most recent ACOEM Practice guidelines. Both moves are pivotal and both recognize the importance of aligning evidence-based drug recommendations with the patient’s condition and phase of care. The formulary development was driven by three major goals. The first is to provide the best evidence-based care and drug recommendations for California’s injured workers, the second is to expedite appropriate treatment, and the third is to reduce the administrative burden and costs within the case management and healthcare systems.
“We are honored to partner with the
Roberts continues, “Our drug formulary dramatically changes the workers’ compensation industry. The marketplace now has a better, more responsible choice when evaluating formularies for their respective jurisdictions. The ACOEM Practice Guidelines meet the very highest standards set by the
ReedGroup, a wholly owned subsidiary of the
ReedGroup’s product, MDGuidelines, is the industry’s leading solution for total health management and workplace productivity. MDGuidelines features the world’s most trusted disability duration tables, predictive modeling, analytic services, and evidence-based Practice Guidelines from ACOEM.